MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$164,076,000
Loss before equity
method investment
-$155,349,000
Loss from equity
method investment
-$8,727,000
Benefit for income taxes
-$138,000
Loss before benefit
for income taxes and...
-$155,487,000
Non Cash Royalty
Revenue Related To Sale...
$54,932,000
License Collaboration
And Other Revenue
$300,000
Loss from operations
-$140,102,000
Total non-operating
income (expense), net
-$15,385,000
Total revenue
$55,232,000
Interest income
$10,438,000
Other income
(expense), net (including...
$361,000
Total operating costs
and expenses
$195,334,000
Non-cash interest
expense on liabilities...
$26,184,000
Research and development
(including 2,636 and 277 for...
$117,330,000
General and
administrative
$68,673,000
Restructuring and impairment
$9,331,000
Back
Back
Income Statement
source: myfinsight.com
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)